
Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …

GSK is to sell its opiates business to Sun Pharmaceuticals for an undisclosed amount, the two companies have announced. The …

The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …

The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …

India-based manufacturer Sun Pharmaceutical Industries is recalling more than 40,000 bottles of its antidepressant venlafaxine hydrochloride, the US regulator has …

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …

India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …

An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …

The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …

Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …

The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …
Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …

Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …
Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …